Lv21
158 积分 2025-09-17 加入
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
8小时前
待确认
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
4个月前
已完结
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus
4个月前
已完结
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
4个月前
已完结
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cells
6个月前
已完结
Proliferative Response of Blood Cells of Patients with Myasthenia gravis to Purified Mammalian Acetylcholine Receptor
6个月前
已完结
The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex
6个月前
已完结
Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States
8个月前
已完结
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering
8个月前
已完结
Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases
8个月前
已完结
皖公网安备34019202002308
